Zeroing in on myofascial pain

Article

Myofascial pain syndrome represents the largest group of poorly recognizd and undertreated acuate and chronic medical problems in clinical practice.

Myofascial pain syndrome (MFPS) represents the largest group of poorly recognized and undertreated acute and chronic medical problems in clinical practice.1 Its prevalence is estimated to be approximately 30% among patients seen in general medical clinics and as high as 85% in pain specialty clinics.2-5 The gynecologic literature cites chronic pelvic pain (CPP) as the most common indication for performing operative laparoscopy.6 CPP has been defined as noncyclic pain lasting at least 6 months that localizes to the anatomic pelvis, anterior abdominal wall, the lumbosacral back, or the buttocks and is severe enough to cause functional disability or necessitate medical care.7

What is myofascial pain syndrome?

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.